Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
But wait, there's more to understand
Both have medical applications in addition to weight loss Semaglutide and tirzepatide can help manage blood glucose for people with diabetes
Retatrutide shows potential for greater efficacy through triple-agonism but awaits Phase 3 results Best For Recommendations# Currently Available Treatment# Recommendation : Tirzepatide Reason : FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data Maximum Weight Loss Potential# Recommendation : Retatrutide Reason : Phase 2 data showed 24.2% weight loss at 48 weeks, exceeding tirzepatide's results, though Phase 3 confirmation is pending Non-Alcoholic Fatty Liver Disease# Recommendation : Retatrutide Reason : Glucagon receptor agonism directly promotes hepatic fat oxidation, showing up to 82% liver fat reduction in trials Type 2 Diabetes Management# Recommendation : Tirzepatide Reason : Proven HbA1c reduction with FDA approval specifically for glycemic control in type 2 diabetes Further Reading# Which Is Better For
Another component is furanocoumarin, which induces phototoxicity in skin
Additionally, exenatide increased cerebral glucose metabolism in regions associated with glucose homeostasis, appetite, and food reward, as observed through [(18)F]2-fluoro-2-deoxy-d-glucose PET/CT scans [17,18,19]
US$ 22.90
US$ 29.83
US$ 23.74
US$ 27.34
